BLRX. BioLineRx Announces Pre-clinical Results Demonstrating the Safety of BL-7010, an Oral Treatment for Celiac Disease and Gluten Sensitivity - The new safety data, as well as pre-clinical efficacy results, presented at the Better Life for Coeliacs 2012 Conference – http://finance.yahoo.com/news/biolinerx-announces-pre-clinical-results-110000962.html
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.